[ad_1]
The National Institute of Hygiene Rafael Rangel (Inhrr) issued a statement to inform about certain drugs with the active ingredient of valsartan in Venezuela after the withdrawal order issued by the. Spanish Agency for Medicines and Health Products (In time)
The impurity detected in the studies shows that it is due to a change in the manufacture of batches, which is why they were removed while the European Medicines Agency (EMA) and other Spanish agencies collaborate with the pharmaceutical company. Zhejiang Huahai to solve the situation.
The institute attached to the Ministry of Health proposed recommendations for the consumption of drugs and urged patients not to interrupt their treatment and to go to health centers. ] In addition, they reported that the product continues to be subject to strict health surveillance and invited the community to notify about any problem or irregularity with the use of the drug
# 25Jul Alert for anyone taking VALSARTAN as part of their treatment for alternative pressure. pic.twitter.com/ODMBIpWPLz – @puzkas
– Report it now (@ReporteYa) 25 July 2018
[ad_2]
Source link
